Scarica l'app Stockscreener
162.43
1.47%
-2.43
Dopo l'orario di chiusura:
162.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Insmed Inc Borsa (INSM) Ultime notizie
Aberdeen Group plc Buys 18,490 Shares of Insmed, Inc. $INSM - MarketBeat
141,517 Shares in Insmed, Inc. $INSM Purchased by Perpetual Ltd - MarketBeat
October Effect Ltd Acquires Shares of 12,121 Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Acquired by Nisa Investment Advisors LLC - MarketBeat
Roger Adsett Sells 88,060 Shares of Insmed (NASDAQ:INSM) Stock - MarketBeat
Insmed (INSM) COO exercises options, sells 88,060 preplanned shares - Stock Titan
Insmed Incorporated (INSM) stock price, news, quote and history - Yahoo Finance Singapore
Insmed (INSM) poised for 2026 upside with potential $1.3B Arikayce sales boost, Roth/MKM initiates buy - MSN
Insmed, Inc. $INSM Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Quarterly Risk: Why is Insmed Incorporated stock going upMarket Activity Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Insmed Inc. R (IM8N.DU) stock price, news, quote and history - Yahoo Finance UK
Insmed (NASDAQ:INSM) Insider Michael Alexander Smith Sells 19,638 Shares - MarketBeat
AVIP AB Mid Cap Core Portfolio's Insmed Inc(INSM) Holding History - GuruFocus
INSM Stock Price, Quote & Chart | INSMED INC (NASDAQ:INSM) - ChartMill
Insmed, Inc. (NASDAQ:INSM) Receives Average Rating of "Buy" from Analysts - MarketBeat
Barclays Raises Price Target for Insmed (INSM) to $237 | INSM St - GuruFocus
INSM (NASDAQ: INSM) insider lists proposed Common share sales in Form 144 - Stock Titan
Insmed (NASDAQ: INSM) details $606M revenue and 150% stock gain - Stock Titan
Options Bulls Could Be Right About This Pharma Stock - Finviz
INSMED (INSM) CLO exercises options and sells 19,638 shares under 10b5-1 plan - Stock Titan
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Insmed (INSM) - The Globe and Mail
Insmed Shares Surge as Arikayce Trial Results Boost Investor Confidence - StocksToTrade
Stifel Lifts PT on Insmed Incorporated (INSM) to $208 From $205 – Here’s Why - Yahoo Finance
Insmed (INSM) jumps as Morgan Stanley raises PT by 28% - MSN
Insmed (INSM) Soars 5.5%: Is Further Upside Left in the Stock? - Yahoo Finance
Insmed (INSM) Jumps as Morgan Stanley Raises PT by 28% - Insider Monkey
10 Stocks Leaving the Market in the Dust Today: Insmed, FMC, Alcoa, and More - Insider Monkey
[144] INSMED Inc SEC Filing - Stock Titan
Insmed (NASDAQ:INSM) Stock Price Up 6.3% Following Analyst Upgrade - MarketBeat
Leerink reiterates Insmed stock rating on TPIP franchise potential By Investing.com - Investing.com India
Stifel reiterates Insmed stock rating on rival trial success By Investing.com - Investing.com Canada
Insmed stock gains on UTHR trial read-through, Morgan Stanley upgrade - Investing.com Canada
Leerink reiterates Insmed stock rating on TPIP franchise potential - Investing.com
Jefferies reiterates Insmed stock rating on inhaled prostacyclin validation By Investing.com - Investing.com Canada
Morgan Stanley upgrades Insmed stock rating on Brinsupri launch data - Investing.com
Morgan Stanley upgrades Insmed stock rating on Brinsupri launch data By Investing.com - Investing.com Canada
Equities Analysts Issue Forecasts for Insmed Q2 Earnings - MarketBeat
SG Americas Securities LLC Buys 49,356 Shares of Insmed, Inc. $INSM - MarketBeat
Positive Phase 3b study update sees Insmed stock drop 1.56% - Traders Union
Nordea Investment Management AB Makes New Investment in Insmed, Inc. $INSM - MarketBeat
Vanguard disaggregates holdings; Insmed (NASDAQ: INSM) shows 0 shares - stocktitan.net
Assenagon Asset Management S.A. Sells 22,419 Shares of Insmed, Inc. $INSM - MarketBeat
INSM Stock: HC Wainwright & Co. Raises Price Target to $245 | IN - GuruFocus
Insmed (NASDAQ:INSM) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
H.C. Wainwright raises Insmed stock price target on ARIKAYCE data - Investing.com
Insmed shares rise on positive results from ARIKAYCE Phase 3b study - MSN
Insmed jumps 6.6% as attention returns to upcoming ENCORE readout for ARIKAYCE - Quiver Quantitative
Insmed CEO reveals Japan patient population exceeds US market for lung disease - AOL.com
Insmed (NASDAQ:INSM) Price Target Raised to $206.00 at Mizuho - MarketBeat
INSM Stock: Mizuho Raises Price Target Amid Stable Outlook | INS - GuruFocus
Insmed (NASDAQ:INSM) Price Target Upgrades Drive Nasdaq Index Focus - Kalkine Media
Wells Fargo Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $177 - Moomoo
INSM: Leerink Partners Raises Price Target, Maintains Outperform Rating | INSM Stock News - GuruFocus
INSM: Wells Fargo Raises Price Target to $177, Reaffirms Overwei - GuruFocus
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (IONS), GE Healthcare Technologies Inc (GEHC) and Insmed (INSM) - The Globe and Mail
B of A Securities Maintains Buy Rating for INSM, Raises Price Ta - GuruFocus
Insmed Stock Hits Day Low of $135.73 Amid Price Pressure - Markets Mojo
0.76%
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):